Early-Stage HCC Percutaneous Locoregional Management: East versus West Perspectives

Hepatocellular carcinoma represents an important cause of death worldwide. Early-stage hepatocellular carcinoma patients not suitable for surgery can be treated with a variety of minimally invasive locoregional interventional oncology techniques. Various guidelines in different countries address the...

Full description

Saved in:
Bibliographic Details
Published inCancers Vol. 15; no. 15; p. 3988
Main Authors Iezzi, Roberto, Posa, Alessandro, Contegiacomo, Andrea, Lee, In Joon, Bale, Reto, Tanzilli, Alessandro, Tenore, Lorenzo, Giuliante, Felice, Gasbarrini, Antonio, Goldberg, Shraga Nahum, Jakobs, Tobias, Pompili, Maurizio, Bargellini, Irene, Sala, Evis, Kim, Hyo-Cheol
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 06.08.2023
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Hepatocellular carcinoma represents an important cause of death worldwide. Early-stage hepatocellular carcinoma patients not suitable for surgery can be treated with a variety of minimally invasive locoregional interventional oncology techniques. Various guidelines in different countries address the treatment of hepatocellular carcinoma, but the actual treatment is usually discussed by a multidisciplinary tumor board in a personalized manner, leading to potential treatment differences based on Western and Eastern perspectives. The aim of this paper is to integrate literature evidence with the eminent experiences collected during a focused session at the Mediterranean Interventional Oncology (MIO) Live Congress 2023.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:2072-6694
2072-6694
DOI:10.3390/cancers15153988